HK185396A - Bcrf1 proteins as inhibitors of interferon--g(g) - Google Patents

Bcrf1 proteins as inhibitors of interferon--g(g)

Info

Publication number
HK185396A
HK185396A HK185396A HK185396A HK185396A HK 185396 A HK185396 A HK 185396A HK 185396 A HK185396 A HK 185396A HK 185396 A HK185396 A HK 185396A HK 185396 A HK185396 A HK 185396A
Authority
HK
Hong Kong
Prior art keywords
interferon
inhibitors
bcrf1
proteins
bcrf1 proteins
Prior art date
Application number
HK185396A
Other languages
English (en)
Inventor
Kevin W Moore
Robert A Kastelein
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK185396A publication Critical patent/HK185396A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK185396A 1989-12-20 1996-01-03 Bcrf1 proteins as inhibitors of interferon--g(g) HK185396A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45393189A 1989-12-20 1989-12-20

Publications (1)

Publication Number Publication Date
HK185396A true HK185396A (en) 1996-10-11

Family

ID=23802631

Family Applications (1)

Application Number Title Priority Date Filing Date
HK185396A HK185396A (en) 1989-12-20 1996-01-03 Bcrf1 proteins as inhibitors of interferon--g(g)

Country Status (27)

Country Link
US (2) US5627155A (de)
EP (1) EP0506836B1 (de)
JP (1) JP2648236B2 (de)
KR (1) KR960015199B1 (de)
CN (1) CN1057012C (de)
AT (1) ATE112317T1 (de)
AU (1) AU7899694A (de)
CA (1) CA2071907C (de)
CZ (1) CZ283049B6 (de)
DE (1) DE69013011T2 (de)
DK (1) DK0506836T3 (de)
ES (1) ES2064082T3 (de)
FI (1) FI104883B (de)
HK (1) HK185396A (de)
HU (1) HU215909B (de)
IE (1) IE72203B1 (de)
IL (1) IL96715A0 (de)
MX (1) MX9203409A (de)
MY (1) MY107449A (de)
NO (1) NO305703B1 (de)
NZ (1) NZ236512A (de)
OA (1) OA09703A (de)
PH (1) PH31669A (de)
PT (1) PT96231B (de)
SK (1) SK635190A3 (de)
WO (1) WO1991009127A1 (de)
ZA (1) ZA9010188B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
JPH04505019A (ja) * 1989-10-23 1992-09-03 シェリング・コーポレーション ガンマインターフェロンのポリペプチド性阻害剤
US6106823A (en) * 1991-01-16 2000-08-22 Schering Corporation Treatment of neoplastic disease with interleukin-10
JP3260368B2 (ja) * 1991-01-16 2002-02-25 シェリング・コーポレーション インターロイキン−１０による腫瘍性疾患の処置
CZ281796B6 (cs) * 1991-08-06 1997-02-12 Schering Corporation Použití interleukinu-10, jeho analoga, agonisty nebo antagonisty pro výrobu léčiva a farmaceutický přípravek je obsahující
US5833976A (en) * 1991-08-06 1998-11-10 Schering Corporation Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity
US6008327A (en) 1992-03-13 1999-12-28 Akzo Nobel, N.V. Peptides and nucleic acid sequences related to the Epstein Barr virus
EP1225226B1 (de) * 1992-03-13 2007-12-05 bioMerieux B.V. Epstein-Barr-Virus verwandte Peptide und Nukleinsäuresegmente
WO1993018783A1 (en) * 1992-03-20 1993-09-30 Schering Corporation Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist
DE69330966T2 (de) * 1993-07-23 2002-06-06 Wolf, Hans DNA-Sequenzen des Epstein-Barr Virus kodierend für ein diagnostisch relevantes Virus-Hüllprotein, durch PCR erhaltene Expressionsklone und Verwendung dieses rekombinanten Antigens in diagnostischen Tests
US5616724A (en) * 1996-02-21 1997-04-01 Cephalon, Inc. Fused pyrrolo[2,3-c]carbazole-6-ones
JP2001512830A (ja) * 1997-08-08 2001-08-28 ニューバイオティックス インコーポレイテッド 生物療法耐性および化学療法耐性を克服するための方法および組成物
EP2791168A1 (de) 2011-11-23 2014-10-22 Amgen Inc. Behandlungsverfahren unter verwendung eines antikörpers gegen interferon-gamma
WO2022016509A1 (zh) * 2020-07-24 2022-01-27 阎忠扬 一种用以筛选药物的方法，以及该药物用于治疗牛皮癣的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583564D1 (de) * 1984-08-23 1991-08-29 Hans Joachim Wolf Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
US5256768A (en) * 1985-12-13 1993-10-26 The Johns Hopkins University Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics

Also Published As

Publication number Publication date
ZA9010188B (en) 1991-08-28
ATE112317T1 (de) 1994-10-15
CN1052608A (zh) 1991-07-03
ES2064082T3 (es) 1995-01-16
FI104883B (fi) 2000-04-28
NO305703B1 (no) 1999-07-12
SK279830B6 (sk) 1999-04-13
JP2648236B2 (ja) 1997-08-27
CA2071907A1 (en) 1991-06-21
CN1057012C (zh) 2000-10-04
HU215909B (hu) 1999-03-29
DE69013011D1 (de) 1994-11-03
NO922456L (no) 1992-06-19
PT96231B (pt) 1998-09-30
DE69013011T2 (de) 1995-02-23
KR960015199B1 (ko) 1996-11-01
HU9202075D0 (en) 1992-10-28
OA09703A (en) 1993-08-30
IL96715A0 (en) 1991-09-16
NO922456D0 (no) 1992-06-19
US5627155A (en) 1997-05-06
FI922770A (fi) 1992-06-16
NZ236512A (en) 1997-07-27
FI922770A0 (fi) 1992-06-16
IE904588A1 (en) 1991-07-03
AU7899694A (en) 1995-02-09
MY107449A (en) 1995-12-31
PT96231A (pt) 1991-09-30
CA2071907C (en) 2000-08-08
CZ635190A3 (en) 1997-09-17
IE72203B1 (en) 1997-04-09
US5736390A (en) 1998-04-07
WO1991009127A1 (en) 1991-06-27
DK0506836T3 (da) 1994-11-28
SK635190A3 (en) 1999-04-13
MX9203409A (es) 1992-07-01
JPH05503846A (ja) 1993-06-24
AU7063691A (en) 1991-07-18
CZ283049B6 (cs) 1997-12-17
HUT65369A (en) 1994-05-02
PH31669A (en) 1999-01-18
AU652732B2 (en) 1994-09-08
EP0506836B1 (de) 1994-09-28
EP0506836A1 (de) 1992-10-07

Similar Documents

Publication Publication Date Title
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
ES8602768A1 (es) Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas.
HK185396A (en) Bcrf1 proteins as inhibitors of interferon--g(g)
RO90639B (ro) Procedeu pentru prepararea tesutului uman activator de plasminogen
IL119461A (en) 4,7-disubstituted -7H-pyrrolo ¬2, 3-d¾pyrimidines
CA2193993A1 (en) New hil-4 mutant proteins used as antagonists or partial agonists of human interleukin 4
GR1002486B (el) Νεα κρυσταλλικη μορφη κυκλοσπορινης, μεθοδος παραγωγης της,φαρμακευτικες συνθεσεις περιεχουσες αυτη και η χρησις της.
ES482097A1 (es) Procedimiento para preparar derivados acilicos de carnitina.
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
HU9201799D0 (en) New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments
EP0273310A3 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva
IL99940A0 (en) Beta-galactoside binding proteins,methods for the production thereof,and pharmaceutical compositions containing the same
ATE168698T1 (de) Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten
TW372873B (en) A novel anti-neoplastic cytokine
ES8200886A1 (es) Procedimiento para la preparacion de derivados del amino-1 propanol-2
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
HUT39599A (en) Process for producing compositions stimulating growth of hair

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20041218